{"id":726764,"date":"2023-01-30T08:24:29","date_gmt":"2023-01-30T13:24:29","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/"},"modified":"2023-01-30T08:24:29","modified_gmt":"2023-01-30T13:24:29","slug":"jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/","title":{"rendered":"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">REDWOOD CITY, Calif., Jan.  30, 2023  (GLOBE NEWSWIRE) &#8212; Jasper Therapeutics, Inc. (Nasdaq: JSPR) (\u201cJasper\u201d), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria and lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell transplant conditioning regimes, announced today that it will host an investor conference call and webcast to provide a corporate update on Tuesday, January 31 from 8:30 am \u2013 9:30 am Eastern Time.<\/p>\n<p align=\"justify\">The conference call will be hosted by the Jasper management team and can be accessed by dialing 1-877-407-4018 (toll-free domestic) or 1-201-689-8471 (international) or by clicking on this <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=eg62raaauMMmmbwP-ViHZBg4UglwEVktvweBoGo05dvHCFhvLCM2w31EJlB4suHFJlwf5JD6eIp_zTaWYpPEAGWqb3DxyShz1wN7wqkTn6LZrh_nfnk6JT8MCtnsoEnWKQWQ3-Rn9_e74qHI5Y4WcHHdLTsb0KXLkAdVIkNdGb8=\" rel=\"nofollow noopener\" target=\"_blank\">link<\/a> and requesting a return call. The live webcast, which will include presentation slides, may be accessed via the investor relations section of the Jasper website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3Z1CHNOJlFJOEt1nnfdZRbyEs2sLsOuPrezTf-R9_0u8oNPjF_r8M4WdCNm-8fuY8i2TzkY_cnElGDS82uwgs75ffhPEtCw-OKyJsGRQ5U4DyosX0-PayzIDdM7-YIRE\" rel=\"nofollow noopener\" target=\"_blank\">www.jaspertherapeutics.com<\/a>. A replay of the webcast will be available for 90 days.<\/p>\n<p align=\"justify\">\n        <strong>About Jasper <\/strong>\n      <\/p>\n<p align=\"justify\">Jasper is a clinical-stage biotechnology company developing briquilimab, a monoclonal antibody targeting c-Kit (CD117) as a therapeutic for chronic mast and stem cell diseases such as chronic urticaria and lower to intermediate risk myelodysplastic syndromes (MDS) and as a conditioning agent for stem cell transplants for rare diseases such as sickle cell disease (SCD), Fanconi anemia (FA) and severe combined immunodeficiency (SCID). To date, briquilimab has a demonstrated efficacy and safety profile in over 130 dosed subjects and healthy volunteers, with clinical outcomes as a conditioning agent in SCID, acute myeloid leukemia (AML), MDS, FA, and SCD. In addition, briquilimab is being advanced as a transformational non-genotoxic conditioning agent for gene therapy.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>John Mullaly (investors)<br \/>LifeSci Advisors<br \/>617-429-3548<br \/>jmullaly@lifesciadvisors.com<\/p>\n<p>Jeet Mahal (investors)<br \/>Jasper Therapeutics<br \/>650-549-1403<br \/>jmahal@jaspertherapeutics.com<\/p>\n<p>Lauren Barbiero (media)<br \/>Real Chemistry<br \/>646-564-2156<br \/>lbarbiero@realchemistry.com<\/p>\n<p \/>\n      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/ZTQ3N2JlODgtZTc2ZS00N2IyLTllOTQtNzgwOWZiODYyZDgwLTUwMDEwMjAwMQ==\/tiny\/Jasper-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REDWOOD CITY, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) &#8212; Jasper Therapeutics, Inc. (Nasdaq: JSPR) (\u201cJasper\u201d), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria and lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell transplant conditioning regimes, announced today that it will host an investor conference call and webcast to provide a corporate update on Tuesday, January 31 from 8:30 am \u2013 9:30 am Eastern Time. The conference call will be hosted by the Jasper management team and can be accessed by dialing 1-877-407-4018 (toll-free domestic) or 1-201-689-8471 (international) or by clicking on this link and requesting a return call. The live webcast, which will &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-726764","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REDWOOD CITY, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) &#8212; Jasper Therapeutics, Inc. (Nasdaq: JSPR) (\u201cJasper\u201d), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria and lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell transplant conditioning regimes, announced today that it will host an investor conference call and webcast to provide a corporate update on Tuesday, January 31 from 8:30 am \u2013 9:30 am Eastern Time. The conference call will be hosted by the Jasper management team and can be accessed by dialing 1-877-407-4018 (toll-free domestic) or 1-201-689-8471 (international) or by clicking on this link and requesting a return call. The live webcast, which will &hellip; Continue reading &quot;Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-30T13:24:29+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023\",\"datePublished\":\"2023-01-30T13:24:29+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/\"},\"wordCount\":302,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/\",\"name\":\"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ==\",\"datePublished\":\"2023-01-30T13:24:29+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/","og_locale":"en_US","og_type":"article","og_title":"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023 - Market Newsdesk","og_description":"REDWOOD CITY, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) &#8212; Jasper Therapeutics, Inc. (Nasdaq: JSPR) (\u201cJasper\u201d), a biotechnology company focused on developing novel antibody therapies targeting c-Kit (CD117) to address diseases such as chronic spontaneous urticaria and lower to intermediate risk myelodysplastic syndromes (MDS) as well as novel stem cell transplant conditioning regimes, announced today that it will host an investor conference call and webcast to provide a corporate update on Tuesday, January 31 from 8:30 am \u2013 9:30 am Eastern Time. The conference call will be hosted by the Jasper management team and can be accessed by dialing 1-877-407-4018 (toll-free domestic) or 1-201-689-8471 (international) or by clicking on this link and requesting a return call. The live webcast, which will &hellip; Continue reading \"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-30T13:24:29+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023","datePublished":"2023-01-30T13:24:29+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/"},"wordCount":302,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/","name":"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ==","datePublished":"2023-01-30T13:24:29+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczODY2MyM1Mzc5OTk2IzUwMDEwMjAwMQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/jasper-therapeutics-to-host-investor-conference-call-and-webcast-on-january-31-2023\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Jasper Therapeutics to Host Investor Conference Call and Webcast on January 31, 2023"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/726764","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=726764"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/726764\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=726764"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=726764"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=726764"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}